Testing effectiveness (Phase 2)Study completedNCT00285103What this trial is testingSPC2996 in Chronic Lymphocytic LeukaemiaWho this might be right forChronic Lymphocytic Leukemia Santaris Pharma A/S 46
Early research (Phase 1)UnknownNCT04381741What this trial is testingCD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 24
Not applicableNo Longer AvailableNCT04705454What this trial is testingLoncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) ADC Therapeutics S.A.
Early research (Phase 1)Ended earlyNCT02706405What this trial is testingJCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more Fred Hutchinson Cancer Center 30
Early research (Phase 1)Ended earlyNCT05618366What this trial is testingTazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma Weill Medical College of Cornell University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323What this trial is testingDuvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RSWho this might be right forChronic Lymphocytic LeukemiaRichter Syndrome Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)UnknownNCT05940051What this trial is testingProspective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma Peng Liu 35
Testing effectiveness (Phase 2)WithdrawnNCT01754870What this trial is testingPhase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) University of Wisconsin, Madison
Testing effectiveness (Phase 2)Looking for participantsNCT06486051What this trial is testingAtlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell LymphomaWho this might be right forLarge B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+1 more Malaghan Institute of Medical Research 60
Testing effectiveness (Phase 2)UnknownNCT03467256What this trial is testingCD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Early research (Phase 1)WithdrawnNCT05037669What this trial is testingProgrammed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Testing effectiveness (Phase 2)Ended earlyNCT05626322What this trial is testingEffects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Pfizer 6
Testing effectiveness (Phase 2)Ended earlyNCT03401853What this trial is testingPembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more University of Washington 18
Early research (Phase 1)Ended earlyNCT00882076What this trial is testingClofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasWho this might be right forLeukemia Milton S. Hershey Medical Center 22
Early research (Phase 1)Study completedNCT02992483What this trial is testingPhase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple MyelomaWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718883What this trial is testingCD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 59
Testing effectiveness (Phase 2)Ended earlyNCT05537766What this trial is testingStudy of Brexucabtagene Autoleucel in Adults With Rare B-cell MalignanciesWho this might be right forRelapsed/Refractory Waldenstrom MacroglobulinemiaRelapsed/Refractory Richter TransformationRelapsed/Refractory Burkitt Lymphoma+1 more Kite, A Gilead Company 19